Cardiac syndrome X is a condition in which patients have no clinical signs of Coronary Artery Disease(CAD) experience angina. Patients with cardiac syndrome X have symptoms
of CAD, but their coronary arteries are clear of blockages. It is not
clear what causes syndrome X, but several theories are being explored.
Syndrome X patients do not seem to have a higher risk of dying early or
having a heart attack, but they often continue to suffer from chest pain
even after treatment.
Syndrome X is more common in women than men:
about 70% of patients are women who are approaching or have already gone
through menopause. In the WISE study, 936 women undergoing cardiac catheterization
for chest pain, 60% did not have a major blockages in the arteries of
their heart. Some of the women in this study may have had chest pain
that was not heart-related.
The tests that differentiate cardiac syndrome X from CAD include a baseline electrocardiagram, an exercise ECG or stress test, an exercise nuclear stress test, and coronary angiography.
When patients with cardiac syndrome X undergo an exercise stress test,
the results may look the same as patients who have CAD. But coronary
angiography procedures, which look for blockages in the coronary
arteries, show the arteries of patients with syndrome X as clear and
normal. Patients may also be evaluated for other conditions that could
be causing the symptoms, including high blood pressure.
Several different types of medicine may relieve the angina pain associated with cardiac syndrome X, including nitroglycerin calcium channel blockers.
Monday, July 23, 2012
Sunday, July 22, 2012
Tuberculosis Skin Test(PPD Skin Test)
The tuberculosis skin test is a skin test which could be used for the detection of immune response to the bacterium(TB).
This immune response can happen when someone currently has active TB infection, or they were exposed to TB infection in the past, or if they received the had been vacinated TB (such as in China and other asian countries). The WHO estimates that 2 billion people worldwide have latent TB infection, while around 3 million people worldwide die of TB per year.
This immune response can happen when someone currently has active TB infection, or they were exposed to TB infection in the past, or if they received the had been vacinated TB (such as in China and other asian countries). The WHO estimates that 2 billion people worldwide have latent TB infection, while around 3 million people worldwide die of TB per year.
The tuberculosis skin test is also known as the tuberculin test or PPD
test. PPD is the abbreviation of purified protein derivative. The mechanism of the PPD test is in fact with the infectionof M. tuberculosis
bacterium. The bacterium produces a delayed hypersensitivity skin reaction ( like athma is also a delayed hypersensitive reaction).The components of the organism are added into the extracts of culture filtrates and as the core elements of
the tuberculin PPD.
Reaction in
the skin to tuberculin PPD begins with T cells which have been sensitized by prior infection. These sensitized T cells are recruited by the
immune system to the skin site, and then release chemical messengers lymphokines. These lymphokines induce induration through local vasodilation leading to fluid deposition known as edema, fibrin deposition, and recruitment of other types of inflammatory cells to the area.
The incubation period of TB are usually 2 to 12 weeks which is necessary for the PPD test to be positive.
Anyone can have a TB test, licluding infants, pregnant
women, or HIV-infected people with no danger. It is only dangerous
in people who have had a severe reaction to a previous tuberculin skin
test.
To perform the PPD test, you will need to see your doctor twice. At the first visit, the health care provider will clean an area of your skin and injecte a small amount of PPD. The needle is gently placed under the top layer of skin, causing a bump (welt) to form which usually goes away in a few hours.
The most important visit is the second visit which is after 48-72 hours of the shot, you must return to your doctor's office to check the area to see if you have had a significant reaction to the PPD test.
And this is done for our international student every year:)
To perform the PPD test, you will need to see your doctor twice. At the first visit, the health care provider will clean an area of your skin and injecte a small amount of PPD. The needle is gently placed under the top layer of skin, causing a bump (welt) to form which usually goes away in a few hours.
The most important visit is the second visit which is after 48-72 hours of the shot, you must return to your doctor's office to check the area to see if you have had a significant reaction to the PPD test.
And this is done for our international student every year:)
Monday, July 16, 2012
Watch Out These Signs For Heart Attack
Some people finally recognize that
they have heart problems until they have a heart attack. Most of the cases,
people who have heart attacks have already had coronary artery disease
for many years. This causes recurring chest pain called angina or
shortness of breath during exercise or exertion.
The most common signs of a heart attack are pain and shortness of breath.
The pain can spread from the chest down the left or right arm, and there can be pain in the back, in the neck or stomach.
The pain can be mild or very strong.
A heart attack often starts with sudden pain in the chest. But the symptoms can often start to be noticeable only slowly. People who have had heart attacks describe the pain as acute, burning or pressing. The pain goes on for more than five minutes and it does not get better when the person rests.
Another sign that it could be a heart attack is if the nitrate medication that a person with coronary artery disease uses for his or her chest pain does not work.
People who have a heart attack are often very afraid, their faces become pale and they break out in sweat. Many people who are having a heart attack have trouble breathing, and have nausea or vomiting. Often these symptoms are much stronger than the chest pain. Particularly for women, these could be the main signs of a heart attack. This is one of the reasons that women more often do not realise they are having a heart attack.
Many women mistakenly believe that heart attacks mostly affect men. But heart attacks are one of the main causes of death in women in industrialised countries. More women die from heart attacks than from breast cancer, for example.
The early signs of a heart attack are not just different from person to person. They can also be different from an earlier heart attack. It is also sometimes possible that a person is not aware of the heart attack. That is called a silent heart attack.
The typical signs of a heart attack that are less frequent than chest pain and shortness of breath include:
While waiting for the emergency service to arrive, you can help a person having a heart attack by:
The most common signs of a heart attack are pain and shortness of breath.
The pain can spread from the chest down the left or right arm, and there can be pain in the back, in the neck or stomach.
The pain can be mild or very strong.
A heart attack often starts with sudden pain in the chest. But the symptoms can often start to be noticeable only slowly. People who have had heart attacks describe the pain as acute, burning or pressing. The pain goes on for more than five minutes and it does not get better when the person rests.
Another sign that it could be a heart attack is if the nitrate medication that a person with coronary artery disease uses for his or her chest pain does not work.
People who have a heart attack are often very afraid, their faces become pale and they break out in sweat. Many people who are having a heart attack have trouble breathing, and have nausea or vomiting. Often these symptoms are much stronger than the chest pain. Particularly for women, these could be the main signs of a heart attack. This is one of the reasons that women more often do not realise they are having a heart attack.
Many women mistakenly believe that heart attacks mostly affect men. But heart attacks are one of the main causes of death in women in industrialised countries. More women die from heart attacks than from breast cancer, for example.
The early signs of a heart attack are not just different from person to person. They can also be different from an earlier heart attack. It is also sometimes possible that a person is not aware of the heart attack. That is called a silent heart attack.
The typical signs of a heart attack that are less frequent than chest pain and shortness of breath include:
- A feeling of tightness or pressure in chest
- Pain or numbness in the upper body that spread to the shoulderblades, the neck and the jaw
- Lightheadedness or fainting
- Dizziness, nausea, vomiting
- Sweating
- Paleness and cold sweating
While waiting for the emergency service to arrive, you can help a person having a heart attack by:
- Helping them keep calm
- Get them comfortable lying on their backs with their upper body a bit elevated
- Loosen any tight clothing
- Make sure they can get fresh air, by opening a window if necessary
- Give them any medication that they have had prescribed for an emergency
Acquired Antimicrobial Resistance Genes
Antimicrobial agents for treatment of infectious diseases is a wonderful achievements in the 20th century. However, soon after their introduction, acquired resistance emerged and this new condition had to be followed with the introduction of new antimicrobial agents.
A large number of different genes in different loci should be responsible for antimicrobial resistance. Identification of these genes is important to understand resistance epidemiology, for verification of nonsusceptible phenotypes and for identification of resistant strains, and then advanced to guide the usage in clinics.
Normally, the detection of resistance genes has been performed by PCR or microarrays. However, in several cases, it is necessary to perform supplementary sequencing of the amplified PCR products. As a result, it is expensive andtime-consuming to performacomplete identification of resistance genes present in a strain collection.
The cost of DNA sequencing has been reduced, almost 10-fold reduction in every five years. As a consequence, DNA sequencing is becoming increasingly affordable for routine use and was recently utilized for complete characterization of antimicrobial resistance and virulence gene content during the safety evaluation of 28 strains intended for use in human nutrition. The challenge is, however, to extract the relevant
information from the large amount of data that is generated by these techniques.
ResFinder is a web server which providing a convenient way of identifying acquired antimicrobial resistance genes in completely sequenced isolates, it can be accessed at www.genomicepidemiology.org. Continuously updation give us new information as new resistance genes are identified.
A large number of different genes in different loci should be responsible for antimicrobial resistance. Identification of these genes is important to understand resistance epidemiology, for verification of nonsusceptible phenotypes and for identification of resistant strains, and then advanced to guide the usage in clinics.
Normally, the detection of resistance genes has been performed by PCR or microarrays. However, in several cases, it is necessary to perform supplementary sequencing of the amplified PCR products. As a result, it is expensive andtime-consuming to performacomplete identification of resistance genes present in a strain collection.
The cost of DNA sequencing has been reduced, almost 10-fold reduction in every five years. As a consequence, DNA sequencing is becoming increasingly affordable for routine use and was recently utilized for complete characterization of antimicrobial resistance and virulence gene content during the safety evaluation of 28 strains intended for use in human nutrition. The challenge is, however, to extract the relevant
information from the large amount of data that is generated by these techniques.
ResFinder is a web server which providing a convenient way of identifying acquired antimicrobial resistance genes in completely sequenced isolates, it can be accessed at www.genomicepidemiology.org. Continuously updation give us new information as new resistance genes are identified.
Sunday, July 8, 2012
Myocardial Infarction Redefined
Myocardial infarction (MI) can be defined from a number of different perspectives related to clinical, electrocardiographic (ECG), biochemical and pathologic characteristics. The term MI also has social and psychological implications, both as an indicator of a major health problem and as a measure of disease prevalence in population statistics and outcomes of clinical trials.
In the distant past, a general consensus existed for the clinical entity designated as MI. In studies of disease
prevalence by the World Health Organization (WHO), MI was defined by a combination of two of three characteristics: typical symptoms (i.e., chest discomfort), enzyme rise and a typical ECG pattern involving the development of Q waves. However, current clinical practice, health care delivery systems, as well as epidemiologic studies and clinical trials, all require a more precise definition of MI.
It is accepted that the term MI reflects a loss of cardiac myocytes (necrosis) caused by prolonged ischemia. Ischemia is the result of a perfusion-dependent imbalance between supply and demand. Ischemia in a clinical setting can be identified from the patient’s history and from the ECG. Possible ischemic symptoms include chest, epigastric, arm, wrist or jaw discomfort with exertion or at rest. The discomfort associated with acute MI usually lasts at least 20 min, but may be shorter in duration. The discomfort may develop in the central or left chest and then radiate to the arm, jaw, back or shoulder.
The presence or absence and the amount of myocardial damage resulting from prolonged ischemia can be assessed by a number of different means, including pathologic examination, measurement of myocardial proteins in the blood, ECG recordings (ST-T segment wave changes, Q waves), imaging modalities such as myocardial perfusion imaging, echocardiography and contrast ventriculography.
Myocardial necrosis results in and can be recognized by the appearance in the blood of different proteins released into the circulation due to the damaged myocytes: myoglobin, cardiac troponins T and I, creatine kinase, lactate dehydrogenase, as well as many others (Fig. 2). Myocardial infarction is diagnosed when blood levels of sensitive and specific biomarkers, such as cardiac troponin and the MB fraction of creatine kinase (CK-MB), are increased in the clinical setting of acute ischemia. These biomarkers reflect myocardial damage but do not indicate its mechanism. Thus, an elevated value in the absence of clinical evidence of ischemia should prompt a search for other causes of cardiac damage, such as myocarditis.
In the distant past, a general consensus existed for the clinical entity designated as MI. In studies of disease
prevalence by the World Health Organization (WHO), MI was defined by a combination of two of three characteristics: typical symptoms (i.e., chest discomfort), enzyme rise and a typical ECG pattern involving the development of Q waves. However, current clinical practice, health care delivery systems, as well as epidemiologic studies and clinical trials, all require a more precise definition of MI.
It is accepted that the term MI reflects a loss of cardiac myocytes (necrosis) caused by prolonged ischemia. Ischemia is the result of a perfusion-dependent imbalance between supply and demand. Ischemia in a clinical setting can be identified from the patient’s history and from the ECG. Possible ischemic symptoms include chest, epigastric, arm, wrist or jaw discomfort with exertion or at rest. The discomfort associated with acute MI usually lasts at least 20 min, but may be shorter in duration. The discomfort may develop in the central or left chest and then radiate to the arm, jaw, back or shoulder.
The presence or absence and the amount of myocardial damage resulting from prolonged ischemia can be assessed by a number of different means, including pathologic examination, measurement of myocardial proteins in the blood, ECG recordings (ST-T segment wave changes, Q waves), imaging modalities such as myocardial perfusion imaging, echocardiography and contrast ventriculography.
Myocardial necrosis results in and can be recognized by the appearance in the blood of different proteins released into the circulation due to the damaged myocytes: myoglobin, cardiac troponins T and I, creatine kinase, lactate dehydrogenase, as well as many others (Fig. 2). Myocardial infarction is diagnosed when blood levels of sensitive and specific biomarkers, such as cardiac troponin and the MB fraction of creatine kinase (CK-MB), are increased in the clinical setting of acute ischemia. These biomarkers reflect myocardial damage but do not indicate its mechanism. Thus, an elevated value in the absence of clinical evidence of ischemia should prompt a search for other causes of cardiac damage, such as myocarditis.
OTITIS MEDIA
Last week we discussed ear infections
in infectious disease class, I am interested in otitis media since it is second
common infection in Childs around 1-6 year old.
Otitis media is inflammation
of the middle ear,
or a middle ear infection. It occurs in the area between the tympanic
membrane and the inner ear, including a duct known as the Eustachian Tube.
Sometimes present as non-purulent fluid within the middle ear cavity. It
affects more boys than girls, occurs more in cold weather. 1/3 of children will
have 3 or more infections by age 3, 90% of children will have at least one
infection by age 6.
Most common bacteria cause otitis
media are: Streptococcus pneumonia, Haemophilus
influenzae(non-typeable), Moraxella catarrhalis, Group A Streptococcus, Staph
aureus, Pseudomonas aeruginosa, RSV assoc. with Acute Otitis Media. Most
common pathogenesis is following an URI in which there is edema of the Eustachian
Tube, leading to blockage. Stasis of these middle ear secretions leads to
infection and irritation. Other factors include allergic rhinitis, nasal
polyps, and adenoidal hypertrophy.
Physical exams will find an
erythematic, opaque, bulging tympanic membrane with loss of anatomic landmarks
including a dull/absent light reflex. Pneumatic Otoscopy reveals that decreased
tympanic membrane mobility and is the gold standard for the diagnosis.
Complications of otitis media are
serious such as hearing loss, acute mastoiditis, cholesteatoma, bacterial
meningitis, epidural abscess, subdural empyema, brain abscess, otitic
hydrocephalus, Lateral sinus thrombosis, etc. Earlier treatment makes better prognosis.
Teatment often use Amoxicillin: 20-40 mg/kg/day tid for 10-14 days.
Monday, July 2, 2012
Myocarditis
Myocarditis could be caused
by varieties of different disorders, many of which are infectious antigens. In
Western countries, viral infections are by far the most common cause of myocarditis.
Bacterial myocarditis is less common but should always be considered in
patients with sepsis and ventricular dysfunction. The prevalence of bacterial myocarditis
is difficult to estimate. The few published studies describe a post-mortem
prevalence ranging from 0.2% to 1.5%. However,
several of these studies included patients with bacterial myocarditis secondary
to endocarditis.
Bacterial
myocarditis can develop by direct bacterial invasion or by toxins elaborated by
the pathogen. The latter is a prominent feature of diphtheric and clostridial infections.
Causes of ventricular dysfunction include: (1) myocardial inflammation and
necrosis; (2) toxin-induced ventricular dysfunction; (3) sepsis-induced myocardial
dysfunction; and (4) ventricular remodeling. Myocardial dysfunction is commonly
associated with severe sepsis. Approximately 50%of patients with severe sepsis and septic shock
can present with left ventricular systolic dysfunction.Right ventricular
dysfunction is also common and usually follows the pattern of left ventricular
dysfunction. The mechanisms involved in myocardial depression are most probably
mediated by circulating cytokines such as tumor necrosis factor, interleukin-1
and interleukin-6. The subset of patients with sepsis-induced myocardial dysfunction
that might have undiagnosed bacterial myocarditis is not known.
The
definitive diagnosis of BM requires endomyocardial biopsy (EMB) or
morphologically proven active myocarditis with evidence of bacterial invasion
or positive tissue cultures. According to the Dallas criteria, active myocarditis is defined as”an
inflammatory infiltrate of the myocardium with necrosis and/or degeneration of
adjacent myocytes not typical of the ischemic damage associated with coronary
heart disease.” EMB is highly specific for the diagnosis of myocarditis, but
its sensitivity is low. Factors such as disease distribution (focal vs diffuse), stage of
the disease process and sampling error influence the sensitivity of EMB. A
clinical diagnosis of bacterial myocarditis may be reasonable when blood
cultures are positive and there is proven active myocarditis on biopsy as long
as other diagnoses have been excluded.
Subscribe to:
Posts (Atom)





